KRYS: Krystal Biotech, Inc. Stock

by  •  • Comments Off on KRYS: Krystal Biotech, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 5,252.25
Enterprise Value ($M) 4,907.39
Book Value ($M) 946.38
Book Value / Share 32.91
Price / Book 5.55
NCAV ($M) 632.59
NCAV / Share 21.99
Price / NCAV 8.30

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.11
Return on Equity (ROE) 0.11

Liquidity (mrq)
Quick Ratio 7.02
Current Ratio 7.28

Balance Sheet (mrq) ($M)
Current Assets 742.04
Assets 1,055.84
Liabilities 109.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 290.51
Operating Income 103.19
Net Income 89.16
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 123.42
Cash from Investing -163.44
Cash from Financing 27.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-05 13G State Street Corp
11-14 13G/A Redmile Group, LLC 2.80 -53.25
11-12 13G/A Fmr Llc 14.94 28.17
07-10 13G/A Vanguard Group Inc 10.05 17.79
07-08 13G/A BlackRock, Inc. 13.80 118.17
2024-02-14 13G/A Avoro Capital Advisors LLC 9.10 81.95

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 84,241 248,655 33.88
2025-02-20 118,163 476,890 24.78
2025-02-19 224,856 589,154 38.17
2025-02-18 98,028 324,530 30.21

(click for more detail)

Similar Companies
KNSA – Kiniksa Pharmaceuticals, Ltd. KPTI – Karyopharm Therapeutics Inc.
KRON – Kronos Bio, Inc. KURA – Kura Oncology, Inc.
KYTX – Kyverna Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io